CN Stock MarketDetailed Quotes

600513 Jiangsu Lianhuan Pharmaceutical

Watchlist
  • 9.70
  • +0.08+0.83%
Trading May 14 10:55 CST
2.77BMarket Cap20.29P/E (TTM)

About Jiangsu Lianhuan Pharmaceutical Company

The company was founded in December 1999 by Yangzhou Pharmaceutical Factory, which was founded in 1958. In March 2003, the company achieved an A-share listing. After years of reform, innovation and development, the company has grown into a national high-tech enterprise integrating R&D, production and sales, ranked among the top 100 enterprises in China's pharmaceutical industry, and has achieved a series of development results. The company's industry is pharmaceutical manufacturing. It is a national high-tech enterprise integrating R&D, production and sales. The company's main business covers the fields of pharmaceutical manufacturing and pharmaceutical distribution. The company's main products include urinary system drugs, antihistamines, cardiovascular drugs, steroidal hormones, antibiotics, etc., covering various pharmaceutical forms of chemical raw materials, injections, and solid formulations, including the national first-class drug epriprit tablets (Chuanlil), second-class new drugs ebastatin tablets (Sudi), and felodipine tablets (bicycladine), felodipine sustained-release capsules (conjugated), simvastatin tablets (indicative), danazol capsules and suppositories, and metformin Products such as speciality tablets (dowa), vermokinase capsules, barofloxacin tablets, sertraline hydrochloride capsules (conjugated optimization), etc. The company was successfully selected to create a world-class “specialized, special and new” model enterprise; was recognized by the Jiangsu Provincial Department of Industry and Information Technology as the second batch of provincial star cloud enterprises in 2022, selected and received the highest five-star rating; passed the AA two-tier integrated management system certification; was rated by the Jiangsu Pharmaceutical Quality Management Association as an excellent enterprise for the 2023 Jiangsu Pharmaceutical Industry Quality Management (QC) Group Activities; the company is a specialized and innovative small and medium-sized enterprise in Jiangsu Province, Jiangsu Industrial Internet Development Demonstration Enterprise (Benchmark Factory Category), rated as “AAA” by Oriental Android (Beijing) International Credit Assessment Center “Credit Enterprise”, won the honor of “National Intellectual Property Demonstration Enterprise”, etc.

Company Profile

Short Name-A联环药业
Symbol-A600513
Company NameJIANGSU LIANHUAN PHARMACEUTICAL Co.,Ltd.
Listing DateMar 19, 2003
Issue Price7.88
Shares Offered20.00M share(s)
FoundedFeb 22, 2000
Listed ExchangeSH Stock Exchange
Legal Representativezhenhua qian
CEOben niu
Secretaryzhenhua qian
Accounting FirmZhonghui Certified Public Accountants (Special General Partnership)
Securities Representativejuan yu
Legal CounselBeijing Jingtian Gongcheng Law Firm Shanghai Branch
Employees877
Phone0514-87813082
Office AddressNo. 9, Health 1st Road, Yangzhou Biohealth Industrial Park, Yangzhou, Jiangsu
Zip Code225127
Registered AddressNo. 9, Health 1st Road, Yangzhou Biohealth Industrial Park, Yangzhou, Jiangsu
Fax0514-87815079
Emaillhgf@lhpharma.com
Business License320000000006964
BusinessPharmaceutical production (produced within the scope specified in the license). It operates and acts as an agent for the import and export business of various types of products and technologies. Authorized use of pharmaceutical-related technology, transfer of results, and service consultation. (For projects requiring approval according to law, business activities can only be carried out after approval by the relevant departments)

Company Executives

  • Name
  • Position
  • Salary
  • zhenhua qian
  • Chairman,directors,Board Secretary
  • 760.30K
  • bin tu
  • Vice Chairman,directors
  • 723.10K
  • wendong liu
  • directors
  • --
  • wenge wu
  • directors
  • 829.20K
  • chunlai xia
  • directors
  • --
  • guangji wang
  • directors
  • --
  • bin zhang
  • Independent directors
  • 80.00K
  • yiqiao hu
  • Independent directors
  • 80.00K
  • ying chen
  • Independent directors
  • 80.00K
  • juan yu
  • Securities affairs representative
  • --
  • baochang yu
  • Chairman of the Supervisory Board,auditors
  • --
  • chunyuan wang
  • auditors
  • --
  • ben niu
  • general manager,Chief engineer
  • 709.80K
  • yi shen
  • Deputy General Manager
  • 674.60K
  • zhangkun hu
  • Deputy General Manager
  • --
  • qingsong chu
  • Deputy General Manager
  • 660.70K
  • hao xue
  • Chief Financial Officer
  • --
  • jing zhang
  • Employee supervisors
  • 307.50K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
%Chg